Peter Langguth

Prof. Peter Langguth

Institute for Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University Mainz, 55099 Mainz, Germany

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2012 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
KBKarl Buch
Karl Buch
TPTanja Peters
Tanja Peters
TNThomas Nawroth
Thomas Nawroth
MSMarkus Sänger
Markus Sänger
HSHeinz Schmidberger
Heinz Schmidberger
Peter LangguthPeter Langguth
Peter Langguth
For studying proliferation and determination of survival of cancer cells after irradiation, the multiple MTT assay, based on the reduction of a yellow water soluble tetrazolium salt to a purple water insoluble formazan dye by living cells was modified from a single-point towards a proliferation assay. This assay can be performed with a large number of samples in short time using multi-well-plates, assays can be performed semi-automatically with a microplate reader. Survival, the calculated parameter in this assay, is determined mathematically. Exponential growth in both control and irradiated groups was proven as the underlying basis of the applicability of the multiple MTT assay. The equivalence to a clonogenic survival assay with its disadvantages such as time consumption was proven in two setups including plating of cells before and after irradiation. Three cell lines (A 549, LN 229 and F 98) were included in the experiment to study its principal and general applicability.

1 June 2014 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
ESErik Sjögren
Erik Sjögren
BABertil Abrahamsson
Bertil Abrahamsson
PAPatrick Augustijns
Patrick Augustijns
DBDieter Becker
Dieter Becker
MBMichael B. Bolger
Michael B. Bolger
Peter LangguthPeter Langguth
Peter Langguth

10 July 2012 in Biopharmaceutics & Drug Disposition
Verified
Journal Article
Closed access
PDF file
ARAsma Radwan
Asma Radwan
GAGordon L. Amidon
Gordon L. Amidon
Peter LangguthPeter Langguth
Peter Langguth

5 September 2020 in Cells
Verified
Journal Article
Open access
PDF file
CSChristian Siewert
Christian Siewert
Heinrich HaasHeinrich Haas
Heinrich Haas
VCVera Cornet
Vera Cornet
SNSara S. Nogueira
Sara S. Nogueira
TNThomas Nawroth
Thomas Nawroth
Peter LangguthPeter Langguth
Peter Langguth
Hybrid nanoparticles from lipidic and polymeric components were assembled to serve as vehicles for the transfection of messenger RNA (mRNA) using different portions of the cationic lipid DOTAP (1,2-Dioleoyl-3-trimethylammonium-propane) and the cationic biopolymer protamine as model systems. Two different sequential assembly approaches in comparison with a direct single-step protocol were applied, and molecular organization in correlation with biological activity of the resulting nanoparticle systems was investigated. Differences in the structure of the nanoparticles were revealed by thorough physicochemical characterization including small angle neutron scattering (SANS), small angle X-ray scattering (SAXS), and cryogenic transmission electron microscopy (cryo-TEM). All hybrid systems, combining lipid and polymer, displayed significantly increased transfection in comparison to lipid/mRNA and polymer/mRNA particles alone. For the hybrid nanoparticles, characteristic differences regarding the internal organization, release characteristics, and activity were determined depending on the assembly route. The systems with the highest transfection efficacy were characterized by a heterogenous internal organization, accompanied by facilitated release. Such a system could be best obtained by the single step protocol, starting with a lipid and polymer mixture for nanoparticle formation.


1 September 2015 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
JAJozef Al-Gousous
Jozef Al-Gousous
Peter LangguthPeter Langguth
Peter Langguth